Home/Filings/4/0001127602-24-022725
4//SEC Filing

Witherspoon Charles 4

Accession 0001127602-24-022725

CIK 0000105770other

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 5:02 PM ET

Size

12.5 KB

Accession

0001127602-24-022725

Insider Transaction Report

Form 4
Period: 2024-08-19
Witherspoon Charles
VP & Treasurer
Transactions
  • Sale

    Common Stock

    2024-08-19$300.00/sh529$158,7001,978.141 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2024-08-195290 total
    Exercise: $102.51From: 2020-02-19Exp: 2029-02-19Stock Options (Right to Buy) (529 underlying)
  • Exercise/Conversion

    Common Stock

    2024-08-19$102.51/sh+529$54,2282,507.141 total
  • Sale

    Common Stock

    2024-08-19$300.00/sh500$150,0001,478.141 total
Footnotes (1)
  • [F1]This award vested in four equal annual installments beginning on February 19, 2020.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001731739

Filing Metadata

Form type
4
Filed
Aug 20, 8:00 PM ET
Accepted
Aug 21, 5:02 PM ET
Size
12.5 KB